ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2120

Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-Scale Observational Study

Kinga Grzybowski1, Ahmer Khan2 and Arthur Lau3, 1Jefferson Einstein Montgomery Hospital, Maspeth, NY, 2Jefferson Einstein Philadelphia Hospital, Philadelphia, 3Jefferson Einstein Hospital, Maple Glen, PA

Meeting: ACR Convergence 2025

Keywords: Bone Resorption, Disparities, pain, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2106–2123) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteitis deformans, commonly referred to as Paget’s Disease of the Bone (PDB), affects adults over the age of 55, mainly of European descent and is characterized by accelerated turnover of bone with abnormalities to remodeling and overgrowth involving multiple regions of the body. Studies have shown a slight male predominance, although others have found equal distributions between genders. Most PDB cases are asymptomatic, however some may develop complications such as arthritis, fractures and diffuse pain. An observational, retrospective cohort study using the TriNetX database was conducted which uses electronic health records from over 140 global collaborative networks to explore both racial and gender differences between patients with PDB.

Methods: Patients 18 years and older were included using ICD-10 code M88 for the diagnosis of PDB. Two cohorts were studied: males and females above the age of 18. The index event was defined as the first appearance of the diagnosis of PDB. Propensity matching included age, race/ethnicity, hypertension, obesity, diabetes, tobacco use, acute myocardial infarction, cerebral infarction, hyperlipidemia and medications commonly used in the treatment of PDB. Outcomes evaluated included mortality, chronic pain syndrome, heart failure, hearing loss, osteosarcoma, osteoporosis, fractures, chronic kidney disease, anxiety, depression and OA. Those who experienced any of the above outcomes prior to the index event were excluded from the study and a risk/risk ratio calculation was measured.

Results: The dataset included 10,972 females and 11,904 males. After propensity matching a total of 4,862 people were excluded, which left 9,007 in each group. The average age after matching was 70.7 in the female group, and 71 in the male group respectively. Most patients were not Hispanic or Latino and were mostly White or of unknown ethnicity. Analysis of the outcomes showed a statistically significant difference in chronic pain (RR 1.18, 95% CI 1.09-1.278, P< 0.0001), osteoporosis (RR 2.44, 95% CI 2.188-2.721, P< 0.0001), anxiety (RR 1.62, 95% CI 1.464-1.794, P< 0.0001), depression (RR 1.49, 95% CI 1.336-1.671, P< 0.0001) and OA (RR 1.295, 95% CI 1.202-1.395, P< 0.0001) in females. Additionally, heart failure (RR 0.864, 95% CI 0.782-0.954, P 0.0038) and chronic kidney disease (RR 0.9, 95% CI 0.818-0.991, P 0.0315) were found to be statistically significant in males. There was no difference in the incidence of mortality, hearing loss, osteosarcoma or fractures between the two cohorts.

Conclusion: The findings demonstrated females with PDB are at a higher risk for chronic pain, osteoporosis, anxiety, depression and OA, whereas men are at higher risk for heart failure and chronic kidney disease. Most participants in this study were non-Hispanic and White, consistent with previous demographic data. However, there was also significant representation from Black/African American and Asian patients. This study signifies that racial and gender differences exist in patients with PDB and more research needs to be conducted to further explain these findings and to potentially identify any confounding or causative variables which may have influenced the observed findings.

Supporting image 1Table 1: Baseline Characteristics of Both Cohorts Before (Left) and After (Right) Propensity Matching

Supporting image 2Table 2: Differences in the Outcomes of Both Cohorts


Disclosures: K. Grzybowski: None; A. Khan: None; A. Lau: None.

To cite this abstract in AMA style:

Grzybowski K, Khan A, Lau A. Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-Scale Observational Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/analyzing-gender-and-racial-disparities-in-pagets-disease-of-bone-a-large-scale-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analyzing-gender-and-racial-disparities-in-pagets-disease-of-bone-a-large-scale-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology